ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Exmoor Pharma Concepts Limited

Exmoor Pharma Concepts Limited is an active company incorporated on 3 March 2004 with the registered office located in Taunton, Somerset. Exmoor Pharma Concepts Limited was registered 21 years ago.
Status
Active
Active since incorporation
Company No
05062865
Private limited company
Age
21 years
Incorporated 3 March 2004
Size
Medium
Balance sheet is under £27M
Under 250 employees
Confirmation
Submitted
Dated 3 March 2025 (8 months ago)
Next confirmation dated 3 March 2026
Due by 17 March 2026 (4 months remaining)
Last change occurred 8 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Full
Next accounts for period 31 March 2025
Due by 31 December 2025 (1 month remaining)
Address
Ground Floor Blackbrook Gate 1
Blackbrook Business Park
Taunton
Somerset
TA1 2PX
United Kingdom
Same address for the past 6 years
Telephone
01398371463
Email
Unreported
People
Officers
7
Shareholders
8
Controllers (PSC)
1
Director • Investment Manager • Lives in UK • Born in Jul 1976
Director • British • Lives in UK • Born in Oct 1980
Director • Director Finance And Consultancy • British • Lives in England • Born in Sep 1964
Director • President And Ceo • American • Lives in United States • Born in Oct 1962
Director • Pharmaceutical Business Manage • British • Lives in UK • Born in Jun 1963
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Rhodes Technologies Limited
Ian Rhodes is a mutual person.
Active
Xention Pharma Limited
Thomas Theodore Casdagli is a mutual person.
Active
Closed Cell Systems Limited
Dr Angela Jane Osborne is a mutual person.
Active
37 Clinical Limited
Ian Rhodes is a mutual person.
Active
37C Limited
Ian Rhodes is a mutual person.
Active
Neurotherapeutics Ltd
Ian Rhodes is a mutual person.
Active
MVM Partners LLP
Thomas Theodore Casdagli is a mutual person.
Active
Exmoor Concepts Limited
Dr Angela Jane Osborne is a mutual person.
Liquidation
Brands
eXmoor
eXmoor is a Cell & Gene Therapy CDMO that offers services supported by 20 years of consultancy experience with over 150 organizations.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
£3.55M
Increased by £1.23M (+53%)
Turnover
£4.78M
Increased by £4.78M (%)
Employees
84
Increased by 22 (+35%)
Total Assets
£28.33M
Increased by £8.33M (+42%)
Total Liabilities
-£3.92M
Decreased by £1.91M (-33%)
Net Assets
£24.41M
Increased by £10.23M (+72%)
Debt Ratio (%)
14%
Decreased by 15.29% (-52%)
Latest Activity
Shailesh Maingi Appointed
2 Months Ago on 28 Aug 2025
Frank Lis Resigned
2 Months Ago on 28 Aug 2025
New Charge Registered
2 Months Ago on 14 Aug 2025
Confirmation Submitted
8 Months Ago on 7 Mar 2025
Full Accounts Submitted
10 Months Ago on 6 Jan 2025
Confirmation Submitted
1 Year 7 Months Ago on 15 Mar 2024
Small Accounts Submitted
1 Year 9 Months Ago on 9 Jan 2024
New Charge Registered
1 Year 11 Months Ago on 21 Nov 2023
Gavin Charles William Sutton Resigned
2 Years 3 Months Ago on 1 Aug 2023
Dr Lucy Foley Appointed
2 Years 3 Months Ago on 1 Aug 2023
Get Credit Report
Discover Exmoor Pharma Concepts Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Change of share class name or designation
Submitted on 26 Sep 2025
Statement of capital following an allotment of shares on 18 July 2025
Submitted on 26 Sep 2025
Resolutions
Submitted on 26 Sep 2025
Termination of appointment of Frank Lis as a director on 28 August 2025
Submitted on 23 Sep 2025
Appointment of Shailesh Maingi as a director on 28 August 2025
Submitted on 23 Sep 2025
Registration of charge 050628650002, created on 14 August 2025
Submitted on 14 Aug 2025
Confirmation statement made on 3 March 2025 with updates
Submitted on 7 Mar 2025
Full accounts made up to 31 March 2024
Submitted on 6 Jan 2025
Confirmation statement made on 3 March 2024 with updates
Submitted on 15 Mar 2024
Statement of capital following an allotment of shares on 12 January 2024
Submitted on 18 Jan 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year